EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--June 28, 2006--SurModics, Inc. (Nasdaq:SRDX - News), and AbbeyMoor Medical announced today the signing of an agreement to jointly develop products intended to site specifically deliver therapeutic agents to treat various diseases of the prostate, such as prostatitis and prostate cancer.
